Cvs Health Stock News

CVS Health (CVS) CEO Karen Lynch terminated a regional sales manager and several executives who supervised him over the handling of sexual harassment complaints that were confirmed.

CVS Health Corp. has “removed” several executives after an internal investigation into the handling of sexual harassment claims, according to a report in the Wall Street Journal.

Chief Executive Karen Lynch has removed several executives following an internal investigation into how they handled sexual-harassment complaints and is overhauling how the company handles such matters.

At least two female CVS employees alleged a New Jersey-based regional store manager touched them inappropriately or harassed them at work, WSJ says.

CVS Health Corp. Chief Executive Karen Lynch has removed several executives, following the health care services and drug store chain''s internal probe into how sexual harassment complaints were handled, according to a report in The Wall Street Journal. Citing people familiar with the matter, the WSJ report said CVS''s investigation came after Lynch became aware of complaints made by two female employees who alleged that they were either harassed or inappropriately touched while at work by a New Jersey-based regional store manager who oversaw hundreds of stores. The manager was dismissed, and senior executives who supervised the manager, the report said. On Friday, Lynch presented to plans senior leaders within the company to create an office to give employees a confidential way to report complaints, the report said. The stock, which rose 0.3% in afternoon trading, has rallied 5.6% over the past three months, while the S&P 500 has lost 9.9%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.

CVS Health (CVS) independent board chair David Dorman will retire from his position in May at the end of his term with the annual meeting.

You don't need to invest in the top tech stocks to get exposure to the metaverse.

CVS Health (CVS) closed at $103.60 in the latest trading session, marking a +1.21% move from the prior day.

CVS Health (CVS) declares $0.55/share quarterly dividend, in line with previous.Forward yield 2.13%Payable May 2; for shareholders of record April 22; ex-div April 21.See CVS…

NowRX's prescription delivery service sets out to disrupt the traditional pharmacy market by offering free same-day delivery. The post Invest in the Future of Pharmacy With NowRX appeared first on Inv

On CNBC’s “ Halftime Report Final Trades ,” Stephen Weiss of Short Hills Capital Partners chose cash, saying “not buying anything here.” The US dollar index (DXY) has gained more than 3% year to … Full story available on Benzinga.com

We believe that CVS Health stock currently appears to be an attractive pick over its peer Target stock due to its comparatively lower valuation and better prospects. CVS trades at about 0.5x trailing

The development will feature 312 affordable units.